The risk of subsequent primary carcinoma of the pancreas in patients with cutaneous malignant melanoma

Cancer

Volumn 82, Issue 9, 1998, Pages 1672-1676

  Schenk, Maryjean ^a   Severson, Richard K ^a   Pawlish, Karen S ^b  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Familial; Malignant melanoma; Melanoma prone; Pancreas; Surveillance, Epidemiology, and End Results

Indexed keywords

ADULT; AGED; ARTICLE; CANCER EPIDEMIOLOGY; CANCER RISK; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MELANOMA; PANCREAS CARCINOMA; PRIORITY JOURNAL; RISK ASSESSMENT; STATISTICAL ANALYSIS;

ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFANT; INFANT, NEWBORN; MALE; MELANOMA; MIDDLE AGED; NEOPLASMS, SECOND PRIMARY; PANCREATIC NEOPLASMS; RISK FACTORS; SKIN NEOPLASMS;

EID: 0032080462     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19980501)82:9<1672::AID-CNCR12>3.0.CO;2-1     Document Type: Article

References (15)

1. Parker SL, Tong T, Bolden S, Wingo PA. Cancer Statistics, 1997. CA Cancer J Clin 1997;47:5-27.
2. Silverman DT, Dunn JA, Hoover RN, Schiffman M, Lillemoe KD, Schoenberg JB, et al. Cigarette smoking and pancreas cancer: a case-control study based on direct interviews. J Natl Cancer Inst 1994;86:1510-6.
3. Fernandez E, La Vecchia C, Decarli A. Attributable risks for pancreatic cancer in northern Italy. Cancer Epidemiol Biomarkers Prev 1996;5:23-7.
4. Swerdlow AJ, Storm HH, Sasieni PD. Risks of second primary malignancy in patients with cutaneous and ocular melanoma in Denmark, 1943-1989. Int J Cancer 1995;61:773-9.
5. Boland SL, Shaw HM, Milton GW. Multiple primary cancers in patients with malignant melanoma. Med J Aust 1976;1:517-9
6. Gutman M, Cnaan A, Inbar M, Shafir R, Chaitchik S, Rozin RR, et al. Are malignant melanoma patients at higher risk for a second cancer? Cancer 1991,68:660-5.
7. Whelan AJ, Bartsch D, Goodfellow PJ. Brief report: a familial syndrome of pancreatic cancer and melanoma with a mutation in the CDKN2 tumor-suppressor gene. N Engl J Med 1995;333(15):975-7.
8. INK4 mutations. N Engl J Med 1995;333(15):970-4.
9. Marks R. Prevention and control of melanoma: the public health approach. CA Cancer J Clin 1996;46:199-216.
10. Ries LA, Miller BA, Hankey BF, Kosary CL, Harras A, Edwards BK. SEER Cancer statistics review: 1973-1991. Tables and graphs. Bethesda (MD): National Cancer Institute; 1994 NIH Pub No 94-2789.
11. Percey C, Van Holten V, Muir C. International classification of diseases for oncology. 2nd edition. Geneva: World Health Organization, 1990.
12. Breslow NE, Day NE. Statistical methods in cancer research. Volume 2. The design and analysis of cohort studies. IARC Sci Publ 1977;82:69 (eq. 2.11).
13. Bergman W, Watson P, de Jong J, Lynch HT, Fusaro RM. Systemic cancer and the FAMMM syndrome. Br J Cancer 1990;61:932-6.
14. Tucker MA, Fraser AM, Elder DE, DuPont G, Organic SM. Risk of melanoma and other cancers in melanoma-prone families. J Invest Dermatol 1993;100(3):350-5S.
15. Caldas C, Hahn SA, da Costa LT, Redston MS, Schutte M, Seymour AB, et al. Frequent somatic mutations and homozygous deletions of the p16 (MTS1) gene in pancreatic adenocarcinoma. Nat Genet 1994;8:27-32.